Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. In RA, the immune system mistakenly recognizes healthy tissues as harmful and launches an immune response against them. This causes persistent inflammation in the synovium, the thin tissue lining the joints.
Over time, ongoing inflammation can damage cartilage, bones, ligaments, and tendons. This can potentially lead to joint deformity and reduced mobility. RA can affect:
- Hands
- Wrists
- Feet
- Knees
- Other joints
The exact cause of RA is unknown. It can occur due to a combination of genetic susceptibility and environmental or lifestyle factors.
Common symptoms of RA include:
- Joint pain
- Joint swelling
- Joint stiffness, especially in the morning or after periods of inactivity
- Tenderness around affected joints
- Warmth around inflamed joints
- Reduced range of motion
- Fatigue
- Weakness
- Loss of appetite
- Mild fever
- Unintentional weight loss
A characteristic feature of RA is that it often affects joints symmetrically. RA can also cause symptoms beyond the joints because it is a systemic autoimmune disease. Some people may develop problems involving the eyes, skin, lungs, blood vessels, or heart. That is why early diagnosis is crucial. Here is where ELISA kits come into play.
What is ELISA?
ELISA stands for enzyme-linked immunosorbent assay. It is a plate-based technique used to detect and measure the amount of analyte in a sample. An analyte can be an antibody, hormone, antigen, protein, peptide, cytokine, enzyme, or other biomolecules.
It relies on antigen-antibody interactions. An enzyme-linked antibody is added to produce a measurable signal. This signal is proportional to the amount of analyte in the sample.
ELISA is known for:
- High sensitivity
- High specificity
- Rapid results
- Affordability
- Versatility and compatibility
ELISA has four formats:
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
In RA, the immune cells become activated and release inflammatory mediators that contribute to synovial inflammation. In addition, B cells produce autoantibodies, including rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs). These antibodies help recognize proteins or other molecules in the body.
Researchers use ELISA immunoassay kits for antibody detection. This further helps them understand disease mechanisms and develop effective treatments.
Role of ELISA Kits in RA Research
Detect Autoantibodies Associated with RA
As already mentioned, our body produces autoantibodies, including RF and ACPA.
RD is an antibody that usually targets the Fc portion of immunoglobulin G (IgG). This can significantly affect immune system activity. On the other hand, ACPAs can be found against citrullinated proteins or peptides. These antibodies are strongly associated with RA.
Researchers use ELISA kits to measure the concentration of these antibodies. This helps them investigate how autoimmunity develops and how antibody levels differ across experimental groups.
Monitor Changes in Antibody Levels
Antibody levels can be different before and after the treatment. So, researchers can collect samples at different stages of disease. They compare antibody levels to investigate whether antibody concentrations change with disease progression, treatment, or other experimental conditions.
In addition, this helps researchers evaluate how experimental interventions influence immune responses. This can further help them develop better treatments and drugs.
Understand Disease Mechanism
RA involves several interconnected immune pathways. Autoantibodies are only one component of this complex process. So, researchers need to investigate different pathways before reaching a decision.
For instance, they use ELISA kits to investigate how B-cell activity and antibody production contribute to chronic inflammation. They also measure inflammatory cytokines, chemokines, and other immune-related proteins. After this, they can study all the biomarkers together. This gives them a better understanding of the molecular mechanisms underlying RA.
Moreover, they can compare antibody levels between healthy controls, individuals with autoimmune conditions, and RA study groups. This can help identify relationships between autoantibody production and other biological processes.
Evaluate Potential RA Treatments
Drug discovery and therapeutic research require reliable methods for the evaluation of biological responses. At times, researchers use ELISA immunoassay kits to measure the quantity of antibody-related biomarkers.
For example, when researchers need to investigate anti-inflammatory or immunomodulatory treatment responses, they can quantify the antibody levels of treated and untreated groups. Changes in autoantibody production can provide information about how an intervention affects specific components of the immune response.
In addition, they can use it to evaluate various cytokines, inflammatory markers, tissue changes, and other endpoints to create a broader picture of treatment effects.
The Bottom Line
Now that you know how ELISA kits help in RA research, what are you waiting for? Find a trusted supplier of ELISA kits. Otherwise, you may not get accurate results and have to compromise on your experiments.
Copyright @smorescience. All rights reserved. Do not copy, cite, publish, or distribute this content without permission.
